View of BCc1, a Chelation-Based Nanomedicine, modulates splenic cytokine networks toward a profile associated with antitumor immunity in 4T1 breast tumor–bearing mice

BCc1, a Chelation-Based Nanomedicine, modulates splenic cytokine networks toward a profile associated with antitumor immunity in 4T1 breast tumor–bearing mice